Long-term clarithromycin therapy in the management of lung transplant recipients

Transplantation

Volumn 87, Issue 10, 2009, Pages 1538-1540

  Benden, Christian ^a   Boehler, Annette ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Azithromycin; Bronchiolitis obliterans syndrome; Clarithromycin; Lung transplantation

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; MACROLIDE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG GRAFT REJECTION; LUNG INFECTION; LUNG TRANSPLANTATION; MALE; MORBIDITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRONCHIOLITIS OBLITERANS; CHILD; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; YOUNG ADULT;

EID: 67649622598     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a492b2     Document Type: Article

References (18)

1. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Resp J 2003; 22: 1007.
2. Christie JD, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth official adult lung and heart/lung transplantation report-2008. J Heart Lung Transplant2008; 27: 957.
3. Fisher AJ, Rutherford RM, Bozzino J, et al. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2005; 5: 537.
4. Benden C, Speich R, Hofbauer GF, et al. Extracorporeal photopheresis after lung transplantation: A 10-year single center experience. Transplantation2008; 86: 1625.
5. Gerhardt SG, McDyer JF, Girgis RE, et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2003; 168: 121.
6. Fietta AM, Meloni F. Lung transplantation: The role of azithromycin in the management of patients with bronchiolitis obliterans syndrome. Curr Med Chem 2008; 15: 716.
7. Speich R, Nicod LP, Aubert JD, et al. Ten years of lung transplantation in Switzerland: Results of the Swiss Lung Transplant Registry. Swiss Med Wkly 2004; 134: 18.
8. Holzmann D, Speich R, Kaufmann T, et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: A 10-year experience. Transplantation 2003; 77: 134.
9. Knower MT, Labella-Walker A, McFadden PM, et al. Clarithromycin for safe and cost-effective reduction of cyclosporine doses in lung allograft recipients. S Med J 2000; 93: 1087.
10. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant2002; 21: 297.
11. Gottlieb J, Szangolies J, Koehnlein T, et al. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation2008; 85: 36.
12. Zuckermann JM. Macrolides and ketolides: Azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am 2004; 18: 621.
13. Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr 2007; 19: 83.
14. Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation2004; 77: 1465.
15. Shirit D, Bendayan D, Gidon S, et al. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 2005; 24: 1440.
16. Verleden GM, Dupont LJ, Vanhaecke J, et al. Effect of azithromycin on bronchiectasis and pulmonary function in a heart-lung transplant patient with severe chronic allograft dysfunction: A case report. J Heart Lung Transplant 2005; 24: 1155.
17. Yates B, Murphy DM, Forrest IA, et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005; 172: 772.
18. Verleden GM, Vanaudenaerde BM, Dupont LJ, et al. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006; 174: 566.